United States · 
Who invested in Quick Study Radiology?
Quick Study Radiology's investors include Advantage Capital, Fletcher Spaght Ventures and Eagle River.
200520062007
$2.0MVenture$3.3MSeries DUnited States · Series D startup
Who invested in Quick Study Radiology
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$5.3Mraised across 2 rounds since 2005, from 2 sources
$2.0MVenture$3.3MSeries D
- Latest round
- Series D, $3.3MJan 2007
- Step-upi
- 1.6×
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $2.0M Jan 2005
- Biggest round
- $3.3M Series D · Jan 2007
- Between rounds
- 2 years from the last two
The rounds
- Jan 2007Series D$3.3M2 new1 returning
From a historical funding record
- Jan 2005
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Fletcher Spaght VenturesGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Quick Study Radiology
How much has Quick Study Radiology raised?
Quick Study Radiology has raised $5.3M across 2 rounds since 2005.
When did Quick Study Radiology last raise?
Quick Study Radiology's most recent round was a Series D of $3.3M in Jan 2007.
What was Quick Study Radiology's biggest round?
Its most recent round, $3.3M in Jan 2007, is also its largest on record.
Who backed Quick Study Radiology first?
Quick Study Radiology's first round on record, in Jan 2005, was backed by Advantage Capital.
What stage is Quick Study Radiology at?
Quick Study Radiology's latest named round is a Series D, in Jan 2007.
Where is Quick Study Radiology based?
Quick Study Radiology is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.